• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
news
Cancer researchers, oncologists and international pharmaceutical company join forces to test a new investigational drug for breast cancer Barcelona, 05…
The first ESMO Women for Oncology Award was recently conferred to VHIO´s Enriqueta Felip during the European Cancer Congress, Vienna,…
• An international study, published in the journal Cancer Discovery, in which the Vall d’Hebron University Hospital and the Vall…
Barcelona, 23 September, 2015.– Susan G. Komen has awarded two Vall d´Hebron Institute of Oncology (VHIO) researchers with Career Catalyst…
Barcelona, September 15, 2015– We can only hope to collectively accelerate the pace in advancing more precisely targeted therapies against…
Source: The European Society for Medical Oncology (ESMO) Lugano, Switzerland, 27 August 2015 — The European Society for Medical Oncology…
Barcelona, 27 August, 2015.– Latest research published in Clinical Cancer Research by the Vall d´Hebron Institute of Oncology´s (VHIO) Stem…
• The phase II study, published in The New England Journal of Medicine, shows that the most common mutation of…
Barcelona, 17 July 2015. – Last week, 10 July, marked the second Vall d´Hebron Research Institute (VHIR) Health Innovation Contest,…
